a developer of gene therapies for fatal and debilitating diseases of the central nervous system
Industry Biotechnology
A.I.dvisor indicates that over the last year, VYGR has been loosely correlated with NTLA. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if VYGR jumps, then NTLA could also see price increases.
Ticker / NAME | Correlation To VYGR | 1D Price Change % | ||
---|---|---|---|---|
VYGR | 100% | -4.73% | ||
NTLA - VYGR | 46% Loosely correlated | -3.65% | ||
ELVN - VYGR | 45% Loosely correlated | +1.46% | ||
EDIT - VYGR | 44% Loosely correlated | -6.68% | ||
KNSA - VYGR | 43% Loosely correlated | -2.73% | ||
PLRX - VYGR | 43% Loosely correlated | -3.84% | ||
More |
Ticker / NAME | Correlation To VYGR | 1D Price Change % |
---|---|---|
VYGR | 100% | -4.73% |
cancer theme (87 stocks) | 53% Loosely correlated | +0.89% |
drugs theme (265 stocks) | 52% Loosely correlated | +5.37% |
biotechnology theme (248 stocks) | 50% Loosely correlated | +5.56% |
central nervous system theme (4 stocks) | 50% Loosely correlated | +0.50% |
gene therapy theme (13 stocks) | 30% Poorly correlated | +1.26% |
More |